HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the

HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection.